Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could an allergy drug boost brain function in williams syndrome?

NCT ID NCT06087757

First seen Apr 04, 2026 · Last updated May 19, 2026 · Updated 7 times

Summary

This study tests whether clemastine, an allergy medicine, can improve thinking, motor skills, and other challenges in people with Williams syndrome. About 30 participants aged 6 to 30 will receive either clemastine or a placebo for several weeks. Researchers will measure changes in IQ, memory, and movement to see if the drug helps.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WILLIAMS SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Child and Adolescent Psychiatry Unit, Sheba Medical Center

    Ramat Gan, Israel

  • Tel Aviv University

    Tel Aviv, Israel

Conditions

Explore the condition pages connected to this study.